z-logo
Premium
P4‐075: LUMIPULSE ® G TOTAL TAU TO β‐AMYLOID 1‐42 RATIO CUT‐POINT DETERMINATION FOR AMYLOID ELIGIBILITY SCREENING
Author(s) -
Kaplow June,
Vandijck Manu,
Moonen Roger,
De Decker Bart,
Zhao Jim,
Lawson John,
Huyck Els,
Le Bastard Nathalie,
Kostanjevecki Vesna,
Luthman Johan
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2478
Subject(s) - medicine , youden's j statistic , amyloid (mycology) , surrogate endpoint , cerebrospinal fluid , clinical trial , cut point , nuclear medicine , pathology , receiver operating characteristic , mathematics , statistics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here